From the Medical Board of the National Psoriasis Foundation: Vaccination in adult patients on systemic therapy for psoriasis

Journal of the American Academy of Dermatology

Volumn 69, Issue 6, 2013, Pages 1003-1013

  Wine Lee, Lara ^a   Keller, Sara C ^a   Wilck, Marissa B ^a   Gluckman, Stephen J ^a   Van Voorhees, Abby S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

biologics; cyclosporine; immunosuppressive therapy; inactivated vaccine; live vaccine; methotrexate; vaccine administration; vaccine counseling

Indexed keywords

ANTHRAX VACCINE; BCG VACCINE; CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CYCLOSPORIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ETRETIN; HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN; INACTIVATED VACCINE; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; MENINGOCOCCUS VACCINE; METHOTREXATE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; ROTAVIRUS VACCINE; TYPHOID VACCINE; USTEKINUMAB; VACCINIA VACCINE; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

ANTHRAX; CHICKENPOX; DIPHTHERIA; DRUG EFFICACY; DRUG SAFETY; HAEMOPHILUS INFECTION; HEPATITIS A; HEPATITIS B; HERPES ZOSTER; HUMAN; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFLUENZA; MEASLES; MENINGOCOCCOSIS; MUMPS; PAPILLOMAVIRUS INFECTION; PERTUSSIS; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; PRIORITY JOURNAL; PSORIASIS; RABIES; REVIEW; ROTAVIRUS INFECTION; RUBELLA; SYSTEMIC THERAPY; TETANUS; TUBERCULOSIS; TYPHOID FEVER; VACCINIA; YELLOW FEVER;

BIOLOGICS; CDC; CENTERS FOR DISEASE CONTROL AND PREVENTION; CYCLOSPORINE; HBV; HEPATITIS B VIRUS; HPV; HUMAN PAPILLOMAVIRUS; IBD; IL; IMMUNOSUPPRESSIVE THERAPY; INACTIVATED VACCINE; INFLAMMATORY BOWEL DISEASE; INTERLEUKIN; LIVE VACCINE; MEASLES, MUMPS, AND RUBELLA; METHOTREXATE; MMR; TNF; TUMOR NECROSIS FACTOR; VACCINE ADMINISTRATION; VACCINE COUNSELING;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; PRACTICE GUIDELINES AS TOPIC; PSORIASIS; RISK FACTORS; TRAVEL; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION;

EID: 84887989984     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.06.046     Document Type: Review

References (102)

1. G.Y. Melmed, A.F. Ippoliti, K.A. Papadakis, T.T. Tran, J.L. Birt, and S.K. Lee Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses Am J Gastroenterol 101 2006 1834 1840
2. E. Sowden, and W.S. Mitchell An audit of influenza and pneumococcal vaccination in rheumatology outpatients BMC Musculoskelet Disord 8 2007 58
3. E.M. McCarthy, E. de Barra, C. Bergin, G. Cunnane, and M. Doran Influenza and pneumococcal vaccination and varicella status in inflammatory arthritis patients Ir Med J 104 2011 208 211
4. Centers for Disease Control and Prevention. Recommended adult immunization schedule-United States 2012, MMWR 2013; 62. Available from: URL: http://www.cdc.gov/vaccines/recs/schedules/downloads/adult/mmwr-adult-schedule. pdf. Accessed May 14, 2012.
5. American Academy of Pediatrics. Immunocompromised children. In: Red book: 2012 Report of the Committee on Infectious Diseases. Pickering LK, ed. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012.
6. J. Zhang, F. Xie, E. Delzell, L. Chen, K.L. Winthrop, and J.D. Lewis Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases JAMA 308 2012 43 49
7. R.K. Avery Vaccination of the immunosuppressed adult patient with rheumatologic disease Rheum Dis Clin North Am 25 1999 567 584 viii
8. M. Wakkee, E. de Vries, P. van den Haak, and T. Nijsten Increased risk of infectious disease requiring hospitalization among patients with psoriasis: a population-based cohort J Am Acad Dermatol 65 2011 1135 1144
9. C. Salliot, and D. van der Heijde Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research Ann Rheum Dis 68 2009 1100 1104
10. A. McLean-Tooke, C. Aldridge, S. Waugh, G.P. Spickett, and L. Kay Methotrexate, rheumatoid arthritis and infection risk: what is the evidence? Rheumatology 48 2009 867 871
11. A.M. Boerbooms, P.J. Kerstens, J.W. van Loenhout, J. Mulder, and L.B. van de Putte Infections during low-dose methotrexate treatment in rheumatoid arthritis Semin Arthritis Rheum 24 1995 411 421
12. M.C. Kapetanovic, T. Saxne, J.-A. Nilsson, and P. Geborek Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients Rheumatology 46 2007 608 611
13. S. Adler, A. Krivine, J. Weix, F. Rozenberg, O. Launay, and J. Huesler Protective effect of A/H1N1 vaccination in immune-mediated disease-a prospectively controlled vaccination study Rheumatology 51 2012 695 700
14. M.C. Kapetanovic, C. Roseman, G. Jönsson, L. Truedsson, T. Saxne, and P. Geborek Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors Arthritis Rheum 63 2011 3723 3732
15. P.J. Mease, C.T. Ritchlin, R.W. Martin, A.B. Gottlieb, S.W. Baumgartner, and D.J. Burge Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept J Rheumatol 31 2004 1356 1361
16. F. Wolfe, K. Michaud, and E.F. Chakravarty Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders Rheumatology 45 2006 1370 1375
17. S. van Assen, O. Elkayam, N. Agmon-Levin, R. Cervera, M.F. Doran, and M. Dougados Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases Autoimmun Rev 10 2011 341 352
18. J. Dreiher, F.S. Kresch, D. Comaneshter, and A.D. Cohen Risk of herpes zoster in patients with psoriasis treated with biologic drugs J Eur Acad Dermatol Venereol 26 2012 1127 1132
19. R. Harpaz, I.R. Ortega-Sanchez, J.F. Seward, and Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC) Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 57 2008 1 30 quiz CE2-4
20. G.S. Pileggi, C.B.S. de Souza, and V.P.L. Ferriani Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids Arthritis Care Res 62 2010 1034 1039
21. J. Zhang, E. Delzell, F. Xie, J.W. Baddley, C. Spettell, and R.M. McMahan The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study Arthritis Res Ther 13 2011 R174
22. S. Borte, U.G. Liebert, M. Borte, and U. Sack Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept Rheumatology 48 2009 144 148
23. M.W. Heijstek, G.C.S. Pileggi, E. Zonneveld-Huijssoon, W. Armbrust, E.P.A.H. Hoppenreijs, and C.S.P.M. Uiterwaal Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis Ann Rheum Dis 66 2007 1384 1387
24. S.K. Wasan, S.E. Baker, P.R. Skolnik, and F.A. Farraye A practical guide to vaccinating the inflammatory bowel disease patient Am J Gastroenterol 105 2010 1231 1238
25. K. Watanabe, K. Takase, S. Ohno, H. Ideguchi, A. Nozaki, and Y. Ishigatsubo Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexate Mod Rheumatol 22 2011 470 473
26. S. Pavy, A. Constantin, T. Pham, L. Gossec, J.-F. Maillefert, and A. Cantagrel Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion Joint Bone Spine 73 2006 388 395
27. H. Montaudié, E. Sbidian, C. Paul, A. Maza, A. Gallini, and S. Aractingi Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity J Eur Acad Dermatol Venereol 25 Suppl 2011 12 18
28. O. Elkayam, M. Yaron, and D. Caspi Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis Ann Rheum Dis 61 2002 623 625
29. O. Kasapçopur, F. Cullu, A. Kamburoǧlu-Goksel, H. Cam, E. Akdenizli, and S. Calýkan Hepatitis B vaccination in children with juvenile idiopathic arthritis Ann Rheum Dis 63 2004 1128 1130
30. T.J. Dengler, N. Strnad, I. Bühring, R. Zimmermann, O. Girgsdies, and W.E. Kübler Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation Transplantation 66 1998 1340 1347
31. P.J. Mazzone, S.B. Mossad, S.D. Mawhorter, A.C. Mehta, R.J. Schilz, and J.R. Maurer The humoral immune response to influenza vaccination in lung transplant patients Eur Respir J 18 2001 971 976
32. N.M. Soesman, G.F. Rimmelzwaan, N.J. Nieuwkoop, W.E. Beyer, H.W. Tilanus, and M.H. Kemmeren Efficacy of influenza vaccination in adult liver transplant recipients J Med Virol 61 2000 85 93
33. P. Duca, J.M. Del Pont, and D. D'Agostino Successful immune response to a recombinant hepatitis B vaccine in children after liver transplantation J Pediatr Gastroenterol Nutr 32 2001 168 170
34. E.A. Hwang, M.J. Kang, S.Y. Han, S.B. Park, and H.C. Kim Viral infection following kidney transplantation: long-term follow-up in a single center Transplant Proc 36 2004 2118 2119
35. A. Rodriguez-Moreno, A.I. Sanchez-Fructuoso, N. Calvo, N. Ridao, J. Conesa, and M. Marques Varicella infection in adult renal allograft recipients: experience at one center Transplant Proc 38 2006 2416 2418
36. C.E. Kashtan, M. Cook, B.M. Chavers, S.M. Mauer, and T.E. Nevins Outcome of chickenpox in 66 pediatric renal transplant recipients J Pediatr 131 1997 874 877
37. T. Arness, R. Pedersen, R. Dierkhising, W. Kremers, and R. Patel Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis Transpl Infect Dis 10 2008 260 268
38. T. Bongartz, A.J. Sutton, M.J. Sweeting, I. Buchan, E.L. Matteson, and V. Montori Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials JAMA 295 2006 2275 2285
39. D.E. Furst The risk of infections with biologic therapies for rheumatoid arthritis Semin Arthritis Rheum 39 2010 327 346
40. C.G. Grijalva, L. Chen, E. Delzell, J.W. Baddley, T. Beukelman, and K.L. Winthrop Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases JAMA 306 2011 2331 2339
41. G. Girolomoni, G. Altomare, F. Ayala, E. Berardesca, P. Calzavara-Pinton, and S. Chimenti Safety of anti-TNF-α agents in the treatment of psoriasis and psoriatic arthritis Immunopharmacol Immunotoxicol 34 2012 548 560
42. Centers for Disease Control and Prevention (US) Epidemiology and prevention of vaccine-preventable diseases W. Atkinson, S. Wolfe, J. Hamborsky, 12th ed. 2012 Public Health Foundation Washington (DC) 9 30
43. G.H. Wong, and D.V. Goeddel Tumor necrosis factors alpha and beta inhibit virus replication and synergize with interferons Nature 323 1986 819 822
44. N. Mjiyad El, S. Bontems, G. Gloire, J. Horion, P. Vandevenne, and E. Dejardin Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promoters J Virol 81 2007 13092 13104
45. N. Balato, F. Gaudiello, A. Balato, and F. Ayala Development of primary varicella infection during infliximab treatment for psoriasis J Am Acad Dermatol 60 2009 709 710
46. S. Torigo, T. Ihara, and H. Kamiya IL-12, IFN-gamma, and TNF-alpha released from mononuclear cells inhibit the spread of varicella-zoster virus at an early stage of varicella Microbiol Immunol 44 2000 1027 1031
47. D.H. Lee, H.S. Kim, Y.W. Song, and K.H. Cho Development of varicella during adalimumab therapy J Eur Acad Dermatol Venereol 21 2007 687 688
48. S.Y. Kim, and D.H. Solomon Tumor necrosis factor blockade and the risk of viral infection Nat Rev Rheumatol 6 2010 165 174
49. J.D. Greenberg, G. Reed, J.M. Kremer, E. Tindall, A. Kavanaugh, and C. Zheng Association of methotrexate and tumor necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry Ann Rheum Dis 69 2010 380 386
50. G. Serac, F. Tubach, X. Mariette, D. Salmon-Céron, P. Ravaud, and F. Lioté Risk of herpes zoster in patients receiving anti-TNF-α in the prospective French RATIO registry J Investig Dermatol 132 2012 726 729
51. I.C. Lawrance, G.L. Radford-Smith, P.A. Bampton, J.M. Andrews, P.-K. Tan, and A. Croft Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience J Gastroenterol Hepatol 25 2010 1732 1738
52. Y. Lu, and A. Bousvaros Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy J Pediatr Gastroenterol Nutr 50 2010 562 565
53. J.-F. Rahier, M. Moutschen, A. Van Gompel, M. Van Ranst, E. Louis, and S. Segaert Vaccinations in patients with immune-mediated inflammatory diseases Rheumatology 49 2010 1815 1827
54. I. García-Doval, B. Pérez-Zafrilla, M.A. Descalzo, R. Roselló, M.V. Hernández, and J.J. Gómez-Reino Incidence and risk of hospitalization due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists Ann Rheum Dis 69 2010 1751 1755
55. A. Strangfeld, J. Listing, P. Herzer, A. Liebhaber, K. Rockwitz, and C. Richter Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents JAMA 301 2009 737 744
56. Atkinson W, Wolfe S, Hamborsky J, editors. Center for Disease Control and Prevention: prevention of vaccine-preventable diseases (the pink book). 12th ed. Washington (DC): Public Health Foundation; 2012.
57. S. Hsu, K.A. Papp, M.G. Lebwohl, J. Bagel, A. Blauvelt, and K.C. Duffin Consensus guidelines for the management of plaque psoriasis Arch Dermatol 148 2012 95 102
58. D. Damjanovic, M. Divangahi, K. Kugathasan, C.-L. Small, A. Zganiacz, and E.G. Brown Negative regulation of lung inflammation and immunopathology by TNF-α during acute influenza infection Am J Pathol 179 2011 2963 2976
59. M. Shale, M. Czub, G.G. Kaplan, R. Panaccione, and S. Ghosh Anti-tumor necrosis factor therapy and influenza: keeping it in perspective Therap Adv Gastroenterol 3 2010 173 177
60. M.C. Kling, A.A. Larian, I. Scordi-Bello, J. Emer, and M.G. Lebwohl Fatal influenza A(H1N1) respiratory tract infection in a patient having psoriasis treated with infliximab Arch Dermatol 146 2010 651 654
61. Y. Lu, D.L. Jacobson, L.A. Ashworth, R.J. Grand, A.L. Meyer, and M.M. McNeal Immune response to influenza vaccine in children with inflammatory bowel disease Am J Gastroenterol 104 2009 444 453
62. S. Salemi, A. Picchianti-Diamanti, V. Germano, I. Donatelli, A. Di Martino, and M. Facchini Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNF-alpha blockers: safety and immunogenicity Clin Immunol 134 2010 113 120
63. J.J. Kobie, B. Zheng, P. Bryk, M. Barnes, C.T. Ritchlin, and D.A. Tabechian Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-TNF Arthritis Res Ther 13 2011 R209
64. A.C.M. Ribeiro, L.K.N. Guedes, J.C.B. Moraes, C.G.S. Saad, N.E. Aikawa, and A.L. Calich Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice Ann Rheum Dis 70 2011 2144 2147
65. O. Elkayam, S. Amir, E. Mendelson, M. Schwaber, I. Grotto, and J. Wollman Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases Arthritis Care Res 63 2011 1062 1067
66. O. Elkayam, A. Bashkin, M. Mandelboim, I. Litinsky, D. Comaheshter, and D. Levartovsky The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis Semin Arthritis Rheum 39 2010 442 447
67. M.A. Ritz, and R. Jost Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease Inflamm Bowel Dis 7 2001 327
68. M. Baghai, D.R. Osmon, D.M. Wolk, L.E. Wold, G.J. Haidukewych, and E.L. Matteson Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept Mayo Clin Proc 76 2001 653 656
69. C. Nuñez-Cornejo, J. Borrás-Blasco, A. Gracia-Perez, J.D. Rosique-Robles, V. Lopez-Camps, and E. Casterã Septic shock and community-acquired pneumonia associated with etanercept therapy Int J Clin Pharmacol Ther 46 2008 193 197
70. O. Elkayam, J. Ablin, and D. Caspi Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases Autoimmun Rev 6 2007 312 314
71. M.C. Kapetanovic, T. Saxne, A. Sjöholm, L. Truedsson, G. Jönsson, and P. Geborek Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis Rheumatology 45 2006 106 111
72. J.L. Kaine, A.J. Kivitz, C. Birbara, and A.Y. Luo Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab J Rheumatol 34 2007 272 279
73. G. Fiorino, L. Peyrin-Biroulet, P. Naccarato, H. Szabò, O.R. Sociale, and S. Vetrano Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study Inflamm Bowel Dis 18 2012 1042 1047
74. O. Elkayam, D. Caspi, T. Reitblatt, D. Charboneau, and J.B. Rubins The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis Semin Arthritis Rheum 33 2004 283 288
75. S. Kane, B. Khatibi, and D. Reddy Higher incidence of abnormal Pap smears in women with inflammatory bowel disease Am J Gastroenterol 103 2008 631 636
76. C. Antoniou, M.G. Kosmadaki, A.J. Stratigos, and A.D. Katsambas Genital HPV lesions and molluscum contagiosum occurring in patients receiving anti-TNF-alpha therapy Dermatology 216 2008 364 365
77. N. Sheron, J. Lau, H. Daniels, J. Goka, A. Eddleston, and G.J. Alexander Increased production of tumor necrosis factor alpha in chronic hepatitis B virus infection J Hepatol 12 1991 241 245
78. R. Pérez-Alvarez, C. Díaz-Lagares, F. García- Hernández, L. Lopez-Roses, P. Brito-Zerón, and M. Pérez-de-Lis Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy Medicine (Baltimore) 90 2011 359 371
79. E. Tanaka, and Y. Urata Risk of hepatitis B reactivation in patients treated with tumor necrosis factor-α inhibitors Hepatol Res 42 2012 333 339
80. S.-J. Chung, J.K. Kim, M.-C. Park, Y.-B. Park, and S.-K. Lee Reactivation of hepatitis B viral infection in inactive HBsAg carriers following anti-tumor necrosis factor-alpha therapy J Rheumatol 36 2009 2416 2420
81. P. Ostuni, C. Botsios, L. Punzi, P. Sfriso, and S. Todesco Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate Ann Rheum Dis 62 2003 686 687
82. M.B. Carroll, and M.A. Forgione Use of tumor necrosis factor alpha inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action Clin Rheumatol 29 2010 1021 1029
83. J.G. Stine, M. Bass, D. Ibrahim, O.S. Khokhar, and J.H. Lewis Dermatologists' awareness of and screening practices for hepatitis B virus infection before initiating tumor necrosis factor-α inhibitor therapy South Med J 104 2011 781 788
84. J.P. Gisbert, L. Menchén, V. García-Sánchez, I. Marín, J.R. Villagrasa, and M. Chaparro Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease Aliment Pharmacol Ther 35 2012 1379 1385
85. J. Moses, N. Alkhouri, A. Shannon, K. Raig, R. Lopez, and L. Danziger-Isakov Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab Am J Gastroenterol 107 2012 133 138
86. E.E. Mast, C.M. Weinbaum, A.E. Fiore, M.J. Alter, B.P. Bell, and L. Finelli A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States, recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults MMWR Recomm Rep 55 2006 1 33 quiz CE1-4
87. K.L. Nichol, J. Wuorenma, and T. von Sternberg Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens Arch Intern Med 158 1998 1769 1776
88. C.E.M. Griffiths, B.E. Strober, P. van de Kerkhof, V. Ho, R. Fidelus-Gort, and N. Yeilding Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis N Engl J Med 362 2010 118 128
89. E. Hak, J. Nordin, F. Wei, J. Mullooly, S. Poblete, and R. Strikas Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations Clin Infect Dis 35 2002 370 377
90. Centers for Disease Control and Prevention (CDC) Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011 MMWR Morb Mortal Wkly Rep 60 2011 1705 1708
91. K.B. Gordon, K.A. Papp, R.G. Langley, V. Ho, A.B. Kimball, and C. Guzzo Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (part II of II): results from analyses of infections and malignancy from pooled phase II and III clinical trials J Am Acad Dermatol 66 2012 742 751
92. I. Betlloch, A. Wasley, C.N. Shapiro, and H.S. Margolis Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 55 2006 1 23
93. V. Failla, and A.F. Nikkels Ustekinumab and herpes zoster Dermatology 222 2011 119 122
94. C. Brodmerkel, Y. Zhu, Q. Jiao, J. Cornacoff, G. Treacy, and M.A. Mascelli Effects of ustekinumab administration on primate/human antigen-recall and humoral immune response functions J Drugs Dermatol 9 2010 677 683
95. J.P. Nuorti, C.G. Whitney, and Centers for Disease Control and Prevention (CDC) Prevention of pneumococcal disease among infants and children-use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine-recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 59 2010 1 18
96. Centers for Disease Control and Prevention (CDC) Local health department costs associated with response to a school-based pertussis outbreak-Omaha, Nebraska, September-November 2008 MMWR Morb Mortal Wkly Rep 60 2011 5 9
97. L.B.S. Gelinck, A.E. van der Bijl, L.G. Visser, T.W.J. Huizinga, R.A. van Hogezand, and G.T. Rijkers Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine Vaccine 26 2008 3528 3533
98. S. Carr, K.J. Allison, L.-A. Van De Velde, K. Zhang, E.Y. English, and A. Iverson Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer J Infect Dis 204 2011 1475 1482
99. A. Cantor, and J.C. Smith Perspectives: vaccine recommendations of the ACIP G.W. Brunette, D.R. Shlim, P.E. Kozarsky, A.J. Magill, Yellow book: CDC health information for international travel 2012 2012 Oxford University Press New York
100. E.C. Jong, and D.O. Freedman Approach to the immunocompromised traveler G.W. Brunette, D.R. Shlim, P.E. Kozarsky, A.J. Magill, Yellow book: CDC health information for international travel 2012 2012 Oxford University Press New York
101. L.G. Visser TNF-α antagonists and immunization Curr Infect Dis Rep 13 2011 243 247
102. L.S. Azevedo, E.P. Lasmar, F.L.C. Contieri, I. Boin, L. Percegona, and L.T.S. Saber Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study Transpl Infect Dis 14 2012 237 241